Response to Patoulias et al. letter regarding article "Twelve weeks of treatment with empagliflozin in patients with heart failure and reduced ejection fraction: A double-blinded, randomized, and placebo-controlled trial"

Jesper Jensen; Massar Omar; Jacob Eifer Møller; Morten Schou

doi:10.1016/j.ahj.2021.02.007

Response to Patoulias et al. letter regarding article "Twelve weeks of treatment with empagliflozin in patients with heart failure and reduced ejection fraction: A double-blinded, randomized, and placebo-controlled trial"

Jesper Jensen, Massar Omar, Jacob Eifer Møller, Morten Schou

Cardiology

Original language	English
Journal	American Heart Journal
Volume	236
Pages (from-to)	106
ISSN	0002-8703
DOIs	https://doi.org/10.1016/j.ahj.2021.02.007
Publication status	Published - Jun 2021

Keywords

Benzhydryl Compounds/therapeutic use
Glucosides
Heart Failure/drug therapy
Humans

Access to Document

10.1016/j.ahj.2021.02.007

Cite this

Response to Patoulias et al. letter regarding article "Twelve weeks of treatment with empagliflozin in patients with heart failure and reduced ejection fraction: A double-blinded, randomized, and placebo-controlled trial". / Jensen, Jesper; Omar, Massar; Møller, Jacob Eifer et al.
In: American Heart Journal, Vol. 236, 06.2021, p. 106.

Research output: Contribution to journal › Comment/debate › Research › peer-review

@article{7953c736b1dd41caa948b7ffabdb9b3d,

title = "Response to Patoulias et al. letter regarding article {"}Twelve weeks of treatment with empagliflozin in patients with heart failure and reduced ejection fraction: A double-blinded, randomized, and placebo-controlled trial{"}",

keywords = "Benzhydryl Compounds/therapeutic use, Glucosides, Heart Failure/drug therapy, Humans",

author = "Jesper Jensen and Massar Omar and M{\o}ller, {Jacob Eifer} and Morten Schou",

year = "2021",

month = jun,

doi = "10.1016/j.ahj.2021.02.007",

language = "English",

volume = "236",

pages = "106",

journal = "American Heart Journal",

issn = "0002-8703",

publisher = "Mosby, Inc",

}

TY - JOUR

T1 - Response to Patoulias et al. letter regarding article "Twelve weeks of treatment with empagliflozin in patients with heart failure and reduced ejection fraction

T2 - A double-blinded, randomized, and placebo-controlled trial"

AU - Jensen, Jesper

AU - Omar, Massar

AU - Møller, Jacob Eifer

AU - Schou, Morten

PY - 2021/6

Y1 - 2021/6

KW - Benzhydryl Compounds/therapeutic use

KW - Glucosides

KW - Heart Failure/drug therapy

KW - Humans

UR - http://www.scopus.com/inward/record.url?scp=85104677699&partnerID=8YFLogxK

U2 - 10.1016/j.ahj.2021.02.007

DO - 10.1016/j.ahj.2021.02.007

M3 - Comment/debate

C2 - 33902821

SN - 0002-8703

VL - 236

SP - 106

JO - American Heart Journal

JF - American Heart Journal

ER -

Response to Patoulias et al. letter regarding article "Twelve weeks of treatment with empagliflozin in patients with heart failure and reduced ejection fraction: A double-blinded, randomized, and placebo-controlled trial"

Keywords

Access to Document

Other files and links

Cite this